Cargando…

Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study

BACKGROUND: Atrial fibrillation (AF) affects up to 10% of people aged ≥65 years, yet a third of all cases remain undetected. Practice-based pharmacists are in an ideal position to facilitate opportunistic AF screening, while increasing general practice capacity at a time of workforce crisis. AIM: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Savickas, Vilius, Veale, Emma L, Bhamra, Sukvinder K, Stewart, Adrian J, Mathie, Alistair, Corlett, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465581/
https://www.ncbi.nlm.nih.gov/pubmed/32576574
http://dx.doi.org/10.3399/bjgpopen20X101042
_version_ 1783577619372965888
author Savickas, Vilius
Veale, Emma L
Bhamra, Sukvinder K
Stewart, Adrian J
Mathie, Alistair
Corlett, Sarah
author_facet Savickas, Vilius
Veale, Emma L
Bhamra, Sukvinder K
Stewart, Adrian J
Mathie, Alistair
Corlett, Sarah
author_sort Savickas, Vilius
collection PubMed
description BACKGROUND: Atrial fibrillation (AF) affects up to 10% of people aged ≥65 years, yet a third of all cases remain undetected. Practice-based pharmacists are in an ideal position to facilitate opportunistic AF screening, while increasing general practice capacity at a time of workforce crisis. AIM: To explore the perspectives of three stakeholder groups involved in the ‘Pharmacists Detecting Atrial Fibrillation’ (PDAF) study to elucidate the facilitators and barriers to pharmacist-led AF screening in general practice. DESIGN & SETTING: A qualitative study took place, comprising homogeneous focus groups with stakeholders in Kent, UK. METHOD: The stakeholder groups — patients, general practice staff (GPS), and clinical pharmacists (CPs) — were recruited using convenience sampling. Audio-recordings were transcribed verbatim and analysed using a deductive Theoretical Domains Framework (TDF) approach. RESULTS: Twenty-five patients, four pharmacists, and nine practice staff participated in six focus groups. Three main themes were identified: knowledge and awareness; prioritisation of resources; and environmental considerations. The public’s lack of awareness of AF-related risks and pharmacist-led screening services was highlighted. Practice-based pharmacists were perceived as an underutilised educational resource which, together with novel electrocardiogram devices, enabled convenient access to screening while reducing GPs’ workload. Participants agreed that AF screening should be incorporated into personalised health checks and at-risk groups should be prioritised, such as care home residents. Patients favoured the general practice environment over the community pharmacy where concerns of privacy, staffing, and commercialisation were raised. CONCLUSION: The findings of this study support the introduction of pharmacist-led AF screening programmes in general practice surgeries. Commissioners should consider the added value of utilising CPs and focus on the delivery of AF screening within an integrated service.
format Online
Article
Text
id pubmed-7465581
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-74655812020-09-10 Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study Savickas, Vilius Veale, Emma L Bhamra, Sukvinder K Stewart, Adrian J Mathie, Alistair Corlett, Sarah BJGP Open Research BACKGROUND: Atrial fibrillation (AF) affects up to 10% of people aged ≥65 years, yet a third of all cases remain undetected. Practice-based pharmacists are in an ideal position to facilitate opportunistic AF screening, while increasing general practice capacity at a time of workforce crisis. AIM: To explore the perspectives of three stakeholder groups involved in the ‘Pharmacists Detecting Atrial Fibrillation’ (PDAF) study to elucidate the facilitators and barriers to pharmacist-led AF screening in general practice. DESIGN & SETTING: A qualitative study took place, comprising homogeneous focus groups with stakeholders in Kent, UK. METHOD: The stakeholder groups — patients, general practice staff (GPS), and clinical pharmacists (CPs) — were recruited using convenience sampling. Audio-recordings were transcribed verbatim and analysed using a deductive Theoretical Domains Framework (TDF) approach. RESULTS: Twenty-five patients, four pharmacists, and nine practice staff participated in six focus groups. Three main themes were identified: knowledge and awareness; prioritisation of resources; and environmental considerations. The public’s lack of awareness of AF-related risks and pharmacist-led screening services was highlighted. Practice-based pharmacists were perceived as an underutilised educational resource which, together with novel electrocardiogram devices, enabled convenient access to screening while reducing GPs’ workload. Participants agreed that AF screening should be incorporated into personalised health checks and at-risk groups should be prioritised, such as care home residents. Patients favoured the general practice environment over the community pharmacy where concerns of privacy, staffing, and commercialisation were raised. CONCLUSION: The findings of this study support the introduction of pharmacist-led AF screening programmes in general practice surgeries. Commissioners should consider the added value of utilising CPs and focus on the delivery of AF screening within an integrated service. Royal College of General Practitioners 2020-06-24 /pmc/articles/PMC7465581/ /pubmed/32576574 http://dx.doi.org/10.3399/bjgpopen20X101042 Text en Copyright © 2020, The Authors https://creativecommons.org/licenses/by/4.0/ This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Research
Savickas, Vilius
Veale, Emma L
Bhamra, Sukvinder K
Stewart, Adrian J
Mathie, Alistair
Corlett, Sarah
Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study
title Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study
title_full Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study
title_fullStr Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study
title_full_unstemmed Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study
title_short Pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study
title_sort pharmacists detecting atrial fibrillation in general practice: a qualitative focus group study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465581/
https://www.ncbi.nlm.nih.gov/pubmed/32576574
http://dx.doi.org/10.3399/bjgpopen20X101042
work_keys_str_mv AT savickasvilius pharmacistsdetectingatrialfibrillationingeneralpracticeaqualitativefocusgroupstudy
AT vealeemmal pharmacistsdetectingatrialfibrillationingeneralpracticeaqualitativefocusgroupstudy
AT bhamrasukvinderk pharmacistsdetectingatrialfibrillationingeneralpracticeaqualitativefocusgroupstudy
AT stewartadrianj pharmacistsdetectingatrialfibrillationingeneralpracticeaqualitativefocusgroupstudy
AT mathiealistair pharmacistsdetectingatrialfibrillationingeneralpracticeaqualitativefocusgroupstudy
AT corlettsarah pharmacistsdetectingatrialfibrillationingeneralpracticeaqualitativefocusgroupstudy